Authors:
Gallego, O
de Mendoza, C
Perez-Elias, MJ
Guardiola, JM
Pedreira, J
Dalmau, D
Gonzalez, J
Moreno, A
Arribas, JR
Rubio, A
Garcia-Arata, I
Leal, M
Domingo, P
Soriano, V
Citation: O. Gallego et al., Drug resistance in patients experiencing early virological failure under atriple combination including indinavir, AIDS, 15(13), 2001, pp. 1701-1706
Authors:
Hernandez-Albujar, S
Arribas, JR
Royo, A
Gonzalez-Garcia, JJ
Pena, JM
Vazquez, JJ
Citation: S. Hernandez-albujar et al., Tuberculous radiculomyelitis complicating tuberculous meningitis: Case report and review, CLIN INF D, 30(6), 2000, pp. 915-921
Authors:
Quereda, C
Corral, I
Laguna, F
Valencia, ME
Tenori, A
Echeverria, JE
Navas, E
Martin-Davila, P
Moreno, A
Moreno, V
Gonzalez-Lahoz, JM
Arribas, JR
Guerrero, A
Citation: C. Quereda et al., Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders, J CLIN MICR, 38(8), 2000, pp. 3061-3067
Authors:
Hernando, A
Pulido, F
Pena, JM
Alberdi, JC
Gonzalez-Garcia, J
Rubio, R
Arribas, JR
Costa, JR
Vazquez, JJ
del Palacio, A
Citation: A. Hernando et al., Influence of a day care hospital on the incidence of hospital admissions of AIDS patients, MED CLIN, 114(18), 2000, pp. 690-693
Authors:
Herranz, P
Arribas, JR
Navarro, A
Pena, JM
Gonzalez, J
Rubio, FA
Casado, M
Citation: P. Herranz et al., Successful treatment of aphthous ulcerations in AIDS patients using topical granulocyte-macrophage colony-stimulating factor, BR J DERM, 142(1), 2000, pp. 171-176
Citation: Jr. Arribas et al., Parvovirus B19-related anemia in an HIV-infected patient: Rapid control after production of neutralizing antibodies during highly active antiretroviral therapy, ANN INT MED, 132(12), 2000, pp. 1011-1011
Authors:
Negredo, E
Paredes, R
Bonjoch, A
Tuldra, A
Fumaz, CR
Gel, S
Garces, B
Johnston, S
Arno, A
Balague, M
Jou, A
Tural, C
Sirera, G
Romeu, J
Cruz, L
Francia, E
Domingo, P
Arrizabalaga, J
Ruiz, I
Arribas, JR
Ruiz, L
Clotet, B
Citation: E. Negredo et al., Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up, ANTIVIR TH, 4, 1999, pp. 23-28